DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Food and Drug Administration.
HEMLIBRA® (emicizumab-kxwh) injection for subcutaneous use, prescribing information.
Initial U.S. approval: 2017 . Available at:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761083s000lbl.pdf . Accessed January 9, 2019
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.